首页 | 本学科首页   官方微博 | 高级检索  
     


Cardiovascular event rate and death in high‐risk secondary prevention patient cohort in Finland: A registry study
Authors:Iiro Toppila,Liisa Ukkola‐  Vuoti,Julia Perttilä  ,Outi Tö  rnwall,Juha Sinisalo,Juha Hartikainen,Seppo Lehto
Affiliation:1. Medaffcon Oy, Espoo Finland ; 2. Amgen AB, Espoo Finland ; 3. BC Platforms AG, Zürich Switzerland ; 4. Heart and Lung Center, Helsinki University Hospital and Helsinki University, Helsinki Finland ; 5. Heart Center, Kuopio University Hospital and School of Medicine, University of Eastern Finland, Kuopio Finland ; 6. Department of Internal Medicine, Lapland Central Hospital, Rovaniemi Finland
Abstract:BackgroundA large number of patients are living with atherosclerotic cardiovascular (CV) disease and thus are at risk of life‐threatening CV events.HypothesisThis study evaluated the risk for a recurrent CV event or death in Finnish real‐world data.MethodsPatients with an incident atherosclerotic CV event between 2012 and 2016 were included in this retrospective registry study and followed for recurrent CV events or death. The risk and risk factors of recurrent CV events or death and time from the first CV event to recurrence were assessed.ResultsA total of 48,405 patients were followed from their first CV event. The event rate was 14.34 events per 100 patient‐years. Multistate models suggested that at 5 years post index CV event, 41.5% of the patients had died or suffered a recurrent CV event. Death was the most common type of subsequent event (61.5%). After the first CV event, there were rapid increases both in recurrent CV events and deaths during the next 6 months. The subsequent CV event was usually of the same type as the first, which was of the cardiac or cerebrovascular cluster.ConclusionsThe incidence of recurrent CV events and all‐cause mortality was high in patients suffering from their first CV event, particularly during the first 6 months after the index event. Death was the most common subsequent event. The event rate accelerated after each additional CV event. This suggests that the acute treatment of the index event should be followed by prompt secondary prevention measures to achieve guideline‐recommended goals as soon as possible.
Keywords:atherosclerosis, cardiovascular diseases, cardiovascular risk factors, myocardial infarction, real‐  world evidence, retrospective study, secondary prevention
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号